Patrick
Patrick is currently pursuing an MD as a first year student at Tufts Medical School. He previously graduated with a 3.99/4.00 GPA and a major in Biology at Bucknell University, where he was a member of the varsity soccer team all 4 years.
Kaiz
Kaiz graduated from Williams College, where he pursued a dual major in biology and psychology. He is currently pursuing his MD at Harvard Medical School.
Sanjana K.
Sanjana graduated summa cum laude and Phi Beta Kappa from the University of Michigan with a major in Molecular, Cellular, and Developmental Biology and minors in Music and the Sociology of Health & Medicine. She is now pursuing her MD at the University of Michigan.
Anne S.
Anne is a practicing pediatrician and the Chief Medical Officer of a community health center organization. She completed her residency at UNC Hospitals, Chapel Hill. Anne holds an MD from Brown, an MBA from Duke, and a BA from Harvard College.
Diane H.
Diane is a MD/MS candidate at Columbia University, where she has recently published a first author manuscript in cardiothoracic surgery research. Previously, she studied Molecular and Cell Biology at the University of California, Berkeley, where she graduated magna cum laude and was inducted into Phi Beta Kappa.
Mackenna
Mackenna graduated summa cum laude from Northeastern University with a degree in Neuroscience and a minor in Global Health. She's presently pursuing her MD at Weill Cornell Medical College.
Drew B.
Drew is currently a resident in emergency medicine at Massachusetts General Hospital and Brigham and Women's Hospital. He holds an MD from Stanford, a DPhil from the University of Oxford, and a BS in Biomedical Engineering, Biochemistry, and Political Science.
Wilton
Wilton is pursuing an MD at Yale School of Medicine (expected graduation in 2026). Previously, he graduated summa cum laude and Phi Beta Kappa from the University of Tennessee, Knoxville.
Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Stephanie D.
Steph graduated summa cum laude with a BS in Biochemistry and Biophysics from Rensselaer Polytechnic Institute. There, she worked in a molecular biology lab studying kinesin proteins. She's now an MD Candidate at the Icahn School of Medicine at Mount Sinai.